Search

everythinglearnresearchcommunity

for

Search:↓

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

CTE can distort results in hair growth trials, so exclude it carefully.

Portable point-of-care testing can improve quick and accurate genetic disorder detection.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

SIM01 significantly reduced post-COVID symptoms and is safe.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The multimedia tool improved patient understanding of PRP treatment for hair loss.

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Impaired LEF1 activation speeds up skin cell development in Hutchinson-Gilford Progeria Syndrome.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

Individualized treatments may help manage Dercum's disease symptoms.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

The supplement aims to improve care for children with alopecia areata.

Glucocorticoids for progressive muscular dystrophy in children don't improve muscle strength or function but do increase certain side effects.